BSX vs HCA
Boston Scientific vs HCA Healthcare — AI-powered side-by-side comparison
| Metric | BSX | HCA |
|---|---|---|
| AI Score | 64 | 58 |
| Price | $44.77 | $406.56 |
| P/E Ratio | 18.87× | 13.23× |
| ROE | 14.9% | 695.7% |
| Revenue Growth YoY | 17.4% | 6.7% |
| Gross Margin | 69.1% | 85.0% |
| Debt / Equity | 0.47× | 54.20× |
| Dividend Yield | — | 0.8% |
| RSI (14) | 47.4 | 56.6 |
| Beta | 0.5774 | 1.1132 |
| Expected Upside | +0.9% | +2.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BSX Full Analysis
HCA Full Analysis